Anusha Sumbal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anusha Sumbal has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Ramish Sumbal
Dow University of Health Sciences, Baba-E-Urdu Road, Karachi, 74200, Pakistan
9 shared publications - Mirza Mehmood Ali Baig
Internal Medicine, Dow University of Health and Sciences, Karachi, Pakistan
3 shared publications Ramish Sumbal
Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan
3 shared publications- Alina Amir
Dow University of Health Sciences; Baba-E-Urdu Road; Karachi; Pakistan, 74200
2 shared publications - Areeba Ikram
Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan
2 shared publications - Muskan Asim Taimuri
Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan
2 shared publications
Latest Publications
- Open Access
- 7 November 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (12) , 8671-8677
CRISPR-Cas9 gene editing for hereditary angioedema: current treatments and emerging therapies
Hereditary angioedema (HAE) is a rare autosomal dominant disorder marked by episodic, non-urticarial swelling due to C1 esterase inhibitor (C1-INH) deficiency or dysfunction, leading to excessive bradykinin-mediated vascular permeability. While current treatments focus on symptomatic control using C1-INH replacement or kallikrein inhibitors, they require frequent administration and do not address the underlying genetic defect. CRISPR-Cas9 gene-editing technologies, particularly the investigational therapy NTLA-2002, offer a transformative approach by targeting the KLKB1 gene to durably reduce plasma kallikrein levels. This narrative review summarizes the pathophysiology and conventional treatments of HAE, and highlights emerging clinical evidence supporting the safety and efficacy of NTLA-2002. Preliminary trials demonstrate substantial reductions in HAE attack frequency and plasma kallikrein, with minimal adverse events. However, concerns about long-term safety, off-target effects, ethical implications, and accessibility remain. CRISPR-based therapeutics such as NTLA-2002 represent a paradigm shift in the management of HAE and underscore the broader potential of in vivo gene editing for genetic disorders.
- 7 November 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (12) , 8671-8677
Open AccessCRISPR-Cas9 gene editing for hereditary angioedema: current treatments and emerging therapies
Hereditary angioedema (HAE) is a rare autosomal dominant disorder marked by episodic, non-urticarial swelling due to C1 esterase inhibitor (C1-INH) deficiency or dysfunction, leading to excessive bradykinin-mediated vascular permeability. While current treatments focus on symptomatic control using C1-INH replacement or kallikrein inhibitors, they require frequent administration and do not address the underlying genetic defect. CRISPR-Cas9 gene-editing technologies, particularly the investigational therapy NTLA-2002, offer a transformative approach by targeting the KLKB1 gene to durably reduce plasma kallikrein levels. This narrative review summarizes the pathophysiology and conventional treatments of HAE, and highlights emerging clinical evidence supporting the safety and efficacy of NTLA-2002. Preliminary trials demonstrate substantial reductions in HAE attack frequency and plasma kallikrein, with minimal adverse events. However, concerns about long-term safety, off-target effects, ethical implications, and accessibility remain. CRISPR-based therapeutics such as NTLA-2002 represent a paradigm shift in the management of HAE and underscore the broader potential of in vivo gene editing for genetic disorders.
- Open Access
- 10 October 2025
- Published by Elsevier in American Heart Journal Plus: Cardiology Research and Practice
- Vol. 59, 100634
Rising heart failure mortality in Alzheimer's patients: A CDC wonder database analysis of trends and disparities from 1999 to 2020
- 10 October 2025
- Published by Elsevier in American Heart Journal Plus: Cardiology Research and Practice
- Vol. 59, 100634
Open AccessRising heart failure mortality in Alzheimer's patients: A CDC wonder database analysis of trends and disparities from 1999 to 2020
- 16 November 2024
- Published by Elsevier in Journal of Orthopaedics
- Vol. 64, 39-46
Complications due to HIV in patients undergoing total joint arthroplasty: A systematic review and meta-analysis
- 16 November 2024
- Published by Elsevier in Journal of Orthopaedics
- Vol. 64, 39-46
Complications due to HIV in patients undergoing total joint arthroplasty: A systematic review and meta-analysis
- 26 July 2024
- Published by SAGE Publications in Shoulder & Elbow
- Vol. 17 (2) , 140-150
Racial disparity in postoperative complications following shoulder arthroplasty (SA): A systematic review and meta-analysis
Introduction: There has been an emphasis on racial disparities in orthopedic surgery. Recently, literature suggested Black and Hispanic patients at increased risk for adverse outcomes after Shoulder Arthroplasty (SA), but data regarding it is sparse and inconclusive. Therefore, we aim to conduct a meta-analysis to assess the role of racial disparity in causing adverse outcomes after SA. Methods: Following PRISMA guidelines, electronic databases PubMed, Scopus, Cochrane, and Google Scholar were queried. Studies meeting inclusion criteria were included. Results were analyzed by pooling Odds ratios along 95% Confidence interval, using random-effects model on RevMan 5.3. Results: A total of 14 selected studies evaluated 1,781,783 patients. We found Black patients at higher risk of post-SA complications than White patients (OR 1.32(95% CI 1.25–1.39; p < 0.00001; I 2 = 0%). No significant risk in Hispanics compared to white patients (OR 0.94(95% CI 0.81–1.09); p = 0.41; I 2 = 65%). Compared to whites, black patients were at higher risk of an extended length of stay, postoperative blood transfusion, sepsis, venous thromboembolism, and non-home discharge. Compared to white patients, Hispanics were at higher risk for postoperative blood transfusion. Whites showed increased risk for readmission. Conclusion: Following SA, Black patients were likely to develop complications compared to White patients but no significant risk in Hispanics compared to Whites.
- 26 July 2024
- Published by SAGE Publications in Shoulder & Elbow
- Vol. 17 (2) , 140-150
Racial disparity in postoperative complications following shoulder arthroplasty (SA): A systematic review and meta-analysis
Introduction: There has been an emphasis on racial disparities in orthopedic surgery. Recently, literature suggested Black and Hispanic patients at increased risk for adverse outcomes after Shoulder Arthroplasty (SA), but data regarding it is sparse and inconclusive. Therefore, we aim to conduct a meta-analysis to assess the role of racial disparity in causing adverse outcomes after SA. Methods: Following PRISMA guidelines, electronic databases PubMed, Scopus, Cochrane, and Google Scholar were queried. Studies meeting inclusion criteria were included. Results were analyzed by pooling Odds ratios along 95% Confidence interval, using random-effects model on RevMan 5.3. Results: A total of 14 selected studies evaluated 1,781,783 patients. We found Black patients at higher risk of post-SA complications than White patients (OR 1.32(95% CI 1.25–1.39; p < 0.00001; I 2 = 0%). No significant risk in Hispanics compared to white patients (OR 0.94(95% CI 0.81–1.09); p = 0.41; I 2 = 65%). Compared to whites, black patients were at higher risk of an extended length of stay, postoperative blood transfusion, sepsis, venous thromboembolism, and non-home discharge. Compared to white patients, Hispanics were at higher risk for postoperative blood transfusion. Whites showed increased risk for readmission. Conclusion: Following SA, Black patients were likely to develop complications compared to White patients but no significant risk in Hispanics compared to Whites.
- 18 June 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 39 (12) , 3128-3135.e3
Prevalence and Clinical Impact of Sarcopenia in Patients Undergoing Total Joint Arthroplasty: A Systematic Review and a Meta-Analysis
- 18 June 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 39 (12) , 3128-3135.e3
Prevalence and Clinical Impact of Sarcopenia in Patients Undergoing Total Joint Arthroplasty: A Systematic Review and a Meta-Analysis
- Open Access
- 17 April 2024
- Published by Elsevier in Arthroplasty Today
- Vol. 27, 101363
Reasons and Risk Factors for Same-Day Discharge Following Total Joint Arthroplasty: A Systematic Review
- 17 April 2024
- Published by Elsevier in Arthroplasty Today
- Vol. 27, 101363
Open AccessReasons and Risk Factors for Same-Day Discharge Following Total Joint Arthroplasty: A Systematic Review
- Top Cited PapersOpen Access
- 1 January 2024
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 11
Can ChatGPT-3.5 Pass a Medical Exam? A Systematic Review of ChatGPT's Performance in Academic Testing
OBJECTIVE: We, therefore, aim to conduct a systematic review to assess the academic potential of ChatGPT-3.5, along with its strengths and limitations when giving medical exams. METHOD: Following PRISMA guidelines, a systemic search of the literature was performed using electronic databases PUBMED/MEDLINE, Google Scholar, and Cochrane. Articles from their inception till April 4, 2023, were queried. A formal narrative analysis was conducted by systematically arranging similarities and differences between individual findings together. RESULTS: After rigorous screening, 12 articles underwent this review. All the selected papers assessed the academic performance of ChatGPT-3.5. One study compared the performance of ChatGPT-3.5 with the performance of ChatGPT-4 when giving a medical exam. Overall, ChatGPT performed well in 4 tests, averaged in 4 tests, and performed badly in 4 tests. ChatGPT's performance was directly proportional to the level of the questions’ difficulty but was unremarkable on whether the questions were binary, descriptive, or MCQ-based. ChatGPT's explanation, reasoning, memory, and accuracy were remarkably good, whereas it failed to understand image-based questions, and lacked insight and critical thinking. CONCLUSION: ChatGPT-3.5 performed satisfactorily in the exams it took as an examinee. However, there is a need for future related studies to fully explore the potential of ChatGPT in medical education.
- 1 January 2024
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 11
Top Cited PapersOpen AccessCan ChatGPT-3.5 Pass a Medical Exam? A Systematic Review of ChatGPT's Performance in Academic Testing
OBJECTIVE: We, therefore, aim to conduct a systematic review to assess the academic potential of ChatGPT-3.5, along with its strengths and limitations when giving medical exams. METHOD: Following PRISMA guidelines, a systemic search of the literature was performed using electronic databases PUBMED/MEDLINE, Google Scholar, and Cochrane. Articles from their inception till April 4, 2023, were queried. A formal narrative analysis was conducted by systematically arranging similarities and differences between individual findings together. RESULTS: After rigorous screening, 12 articles underwent this review. All the selected papers assessed the academic performance of ChatGPT-3.5. One study compared the performance of ChatGPT-3.5 with the performance of ChatGPT-4 when giving a medical exam. Overall, ChatGPT performed well in 4 tests, averaged in 4 tests, and performed badly in 4 tests. ChatGPT's performance was directly proportional to the level of the questions’ difficulty but was unremarkable on whether the questions were binary, descriptive, or MCQ-based. ChatGPT's explanation, reasoning, memory, and accuracy were remarkably good, whereas it failed to understand image-based questions, and lacked insight and critical thinking. CONCLUSION: ChatGPT-3.5 performed satisfactorily in the exams it took as an examinee. However, there is a need for future related studies to fully explore the potential of ChatGPT in medical education.
- 30 May 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 32 (10) , 2172-2179
Risk factors for 30-day readmission following shoulder arthroscopy: a systematic review
- 30 May 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 32 (10) , 2172-2179
Risk factors for 30-day readmission following shoulder arthroscopy: a systematic review